Dissolution variability unexplained during tech transfer – how to redesign formulation strategy


Published on 24/04/2026

Dissolution Variability During Tech Transfer: A Practical Guide to Reformulating Strategies

Dissolution variability can be a critical issue during the tech transfer of pharmaceutical products, particularly affecting bioavailability, product quality, and regulatory compliance. This challenge becomes pivotal when formulating a strategy that can ensure consistency and reliability through scale-up. After reading this article, you will be equipped with a comprehensive playbook detailing actionable steps to identify, analyze, and mitigate dissolution variability.

This playbook is designed for pharmaceutical professionals involved in production, quality control, quality assurance, engineering, and regulatory affairs. It highlights immediate actions, systematic investigations, effective controls, and inspection-ready documentation necessary to address dissolution variability during tech transfers.

Symptoms/Signals on the Floor or in the Lab

Dissolution variability often surfaces as unexpected results during routine testing or product evaluations. Key symptoms and signals include:

  • Unexpected Dissolution Profiles: Deviations from established dissolution profiles can indicate issues in formulation stability or integrity.
  • Batch-to-Batch Variability: Significant differences between batches regarding
dissolution rates or limits, typically seen in trending data.
  • Increased Out-of-Specification (OOS) Results: More frequent OOS results during release testing can signal underlying issues with formulation.
  • Early identification and documentation of these symptoms are critical pathways to initiating investigation, fostering a culture of quality and accountability across departments.

    Likely Causes

    Understanding the root causes of dissolution variability is crucial for formulating effective remedial strategies. The following categories encapsulate the primary causes:

    Category Likely Causes
    Materials Variability in raw materials, such as active pharmaceutical ingredients (APIs) or excipients, that may not meet specified quality attributes.
    Method Inconsistencies in analytical methods or the dissolution apparatus setup, including calibration issues and method parameters not being updated.
    Machine Malfunctions or variability in dissolution testing equipment that may interfere with the results.
    Man Operator errors or lack of training that could lead to inaccurate testing or recording.
    Measurement Poor data handling practices, including inadequate sampling methods or analytical inconsistencies that contribute to variability.
    Environment Environmental factors such as temperature or humidity fluctuations affecting the stability of both the product and testing apparatus.

    Immediate Containment Actions (first 60 minutes)

    Immediate action is essential to contain dissolution variability issues before they escalate. Follow these steps within the first hour:

    1. Cease Production: Stop any ongoing processes involving the identified batch to prevent further discrepancies.
    2. Isolate Affected Batches: Quarantine the batches exhibiting variability to prevent inadvertent release.
    3. Notify Relevant Personnel: Inform quality control and quality assurance teams to initiate an investigation.
    4. Conduct Initial Testing: Perform rapid dissolution testing to assess whether the variability is systemic or isolated.
    5. Document All Actions: Record all containment actions taken, including personnel involved, to ensure traceability during investigation.

    Investigation Workflow

    The next step is to conduct a systematic investigation to uncover the root cause of the variability. The following steps outline a comprehensive approach:

    1. Data Collection: Gather all data associated with the affected batches. This includes raw material specifications, manufacturing records, and testing results.
    2. Graphical Trend Analysis: Utilize tools like control charts to visualize trends in dissolution data that signal deviations.
    3. Cross-Departmental Review: Engage teams from production, quality control, and engineering to obtain varied perspectives on the issues.
    4. Develop a Preliminary Report: Summarize findings from data analysis and observations, integrating initial hypotheses for further testing.

    Root Cause Tools

    Several tools can be employed to dive deeper into the root cause of dissolution variability. Here are three effective methodologies:

    • 5-Why Analysis: Utilize this tool by asking “why” repeatedly (usually five times) to trace back through causal chains.
    • Fishbone Diagram: A visual representation can help map out causes across different categories, making it easier to identify potential root causes.
    • Fault Tree Analysis: Employ this systematic approach to decompose failure states into their causal elements, useful in complex scenarios.

    Choosing the right tool often depends on the complexity of the issue and the operational constraints. It is critical to determine which methodology best suits the nature of your variability challenge.

    CAPA Strategy

    Once the root cause has been identified, implement a corrective and preventive action (CAPA) strategy:

    1. Correction: Fix the immediate issues causing variability in the affected batches. This could include re-testing, re-calibrating equipment, or reformulating products.
    2. Corrective Action: Implement process improvements addressing the root causes. This can involve updating SOPs, enhancing training, or upgrading technology.
    3. Preventive Action: Adopt strategies to prevent recurrence, including regular audits, continuous training, and systemic reviews of production processes.

    Control Strategy & Monitoring

    Monitoring and control strategies form the backbone of process reliability, and the following actions should be incorporated:

    1. Statistical Process Control (SPC): Employ SPC techniques to monitor process variation and detect shifts that could indicate emerging issues.
    2. Sampling Plans: Develop robust sampling plans to ensure representative data during dissolution testing during and post-tech transfer.
    3. Alarms and Alerts: Configure alarms for critical quality attributes to prompt immediate investigations upon deviations from defined limits.
    4. Verification Processes: Introduce regular verification steps post-tech transfers to confirm that dissolution profiles align with requirements.

    Validation / Re-qualification / Change Control Impact

    A critical aspect of regulatory compliance involves understanding the implications of dissolution variability on validation and change control:

    • Validation: If formulations are modified to address variability, they must undergo re-validation to ensure altered processes remain within compliance.
    • Re-qualification: Equipment used in dissolution tests may need re-qualification after changes to processes or methodologies.
    • Change Control: Document all changes in a formal change control system to maintain an audit trail and ensure all stakeholders are informed of updates.

    Inspection Readiness: What Evidence to Show

    Preparing for inspections involves meticulous documentation and record-keeping. The following items should be available for review:

    Related Reads

    • Records: Ensure testing records for all batches are accessible, showcasing deviations and investigations.
    • Logs: Keep detailed logs of all corrective actions undertaken and their outcomes, including review dates and personnel involved.
    • Batch Documentation: Present batch records demonstrating compliance with formulation and process specifications.
    • Deviations and CAPAs: Document all deviations and corresponding CAPA plans, ensuring traceability and proof of compliance.

    FAQs

    What are the common causes of dissolution variability?

    Common causes include raw material inconsistencies, method discrepancies, and equipment failures.

    How can I identify dissolution variability early?

    Regular testing and trend analysis of dissolution profiles can help identify issues promptly.

    What immediate actions should be taken when variability is detected?

    Immediately cease production, isolate batches, notify teams, conduct initial testing, and document actions.

    How do root cause tools assist in problem-solving?

    They provide structured approaches to identify underlying issues, ensuring corrective actions address the real causes.

    Why is CAPA important in addressing dissolution variability?

    CAPA ensures that not only is the immediate issue resolved, but also that future occurrences are prevented through systematic improvements.

    What role does SPC play in monitoring processes?

    SPC allows for real-time monitoring of process variations, helping detect issues before they escalate.

    What documentation is essential for inspection readiness?

    Key documents include testing records, logs of corrective actions, batch documentation, and records of deviations and CAPAs.

    How does change control impact tech transfer processes?

    Change control ensures that any adjustments made during a tech transfer are documented and communicated effectively to maintain compliance.

    What should companies do to ensure formulation consistency?

    Implement robust quality controls, regular training, and inspections to guarantee formulation adheres to established specifications.

    When should re-validation be conducted?

    Re-validation is required whenever changes to formulation or process are made to ensure compliance with quality standards.

    How can environmental factors affect dissolution testing?

    Environmental conditions such as temperature and humidity can impact the stability and performance of the product and lead to variability.

    What is the importance of cross-departmental collaboration during investigations?

    Collaboration allows different perspectives to identify root causes effectively and implement comprehensive solutions integrating various expertise.

    Pharma Tip:  Bioavailability risk flagged during tech transfer – CMC risk assessment and mitigation